Correlation Between Akero Therapeutics and Conduit Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Akero Therapeutics and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akero Therapeutics and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akero Therapeutics and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Akero Therapeutics and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akero Therapeutics with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akero Therapeutics and Conduit Pharmaceuticals.
Diversification Opportunities for Akero Therapeutics and Conduit Pharmaceuticals
-0.62 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Akero and Conduit is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding Akero Therapeutics and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Akero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akero Therapeutics are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Akero Therapeutics i.e., Akero Therapeutics and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between Akero Therapeutics and Conduit Pharmaceuticals
Given the investment horizon of 90 days Akero Therapeutics is expected to generate 0.18 times more return on investment than Conduit Pharmaceuticals. However, Akero Therapeutics is 5.6 times less risky than Conduit Pharmaceuticals. It trades about 0.12 of its potential returns per unit of risk. Conduit Pharmaceuticals is currently generating about 0.02 per unit of risk. If you would invest 2,867 in Akero Therapeutics on August 24, 2024 and sell it today you would earn a total of 253.00 from holding Akero Therapeutics or generate 8.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 50.0% |
| Values | Daily Returns |
Akero Therapeutics vs. Conduit Pharmaceuticals
Performance |
| Timeline |
| Akero Therapeutics |
| Conduit Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Weak
Akero Therapeutics and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akero Therapeutics and Conduit Pharmaceuticals
The main advantage of trading using opposite Akero Therapeutics and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akero Therapeutics position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.| Akero Therapeutics vs. ZyVersa Therapeutics | Akero Therapeutics vs. Sonnet Biotherapeutics Holdings | Akero Therapeutics vs. Zura Bio Limited | Akero Therapeutics vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |